NCT06731894View on ClinicalTrials.gov

Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 27, 2025

Primary Completion Date

January 7, 2028

Study Completion Date

January 7, 2028

Conditions
Breast CarcinomaChemotherapy-Induced Peripheral NeuropathyColon Carcinoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo urine sample collection

DRUG

Cannabidiol

Given PO

DRUG

Dronabinol

Given PO

DRUG

Placebo Administration

Given PO

OTHER

Survey Administration

Ancillary studies

Trial Locations (2)

91010

RECRUITING

City of Hope Medical Center, Duarte

92618

RECRUITING

City of Hope at Irvine Lennar, Irvine

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER